share_log

Rising Food Costs and Supply Chain Strains: How Agritech Companies Are Responding

Rising Food Costs and Supply Chain Strains: How Agritech Companies Are Responding

食品成本上漲和供應鏈緊張:農業科技公司如何應對
PR Newswire ·  08/19 09:45

USA News Group Commentary
Issued on behalf of Bee Vectoring Technologies International Inc.

美國資訊集團評論
代表Bee Vectoring Technologies International Inc.發佈

VANCOUVER, BC, Aug. 19, 2024 /PRNewswire/ -- USA News Group – A new commentary from the University of Guelph is sounding the alarm about our fragile food supply chain, that the authors claim was "built for a world that no longer exists". According to the UN World Food Program USA, hunger, famine, and rising food costs are happening around the world. Helping to meet today's food needs around the world, the World Economic Forum is applauding advancements in a vast and complex supply chain, pointing towards a global food market expected to be worth $9.12 trillion, growing at a CAGR of 6.7%. Among the groups working to better secure the global food supply chain from crop to plater are innovative companies that include Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF), Cal-Maine Foods, Inc. (NASDAQ: CALM), Calavo Growers, Inc. (NASDAQ: CVGW), Darling Ingredients Inc. (NYSE: DAR), and FMC Corporation (NYSE: FMC).

加拿大BC省溫哥華市,2024年8月19日/PRNewswire/ -- 美國新聞集團——來自Guelph大學的一篇新評論提醒人們,我們脆弱的食品供應鏈正面臨警報,作者稱它是「建立在一個不復存在的世界上」。根據聯合國世界糧食計劃USA,全球飢餓、饑荒和食品成本上漲的現象在發生。爲了滿足全球當下的食品需求,世界經濟論壇讚揚了龐大而複雜的供應鏈取得的進步,指向了一個預計將達到9.12萬億美元、以6.7%的複合年增長率增長的全球食品市場。致力於保障從種植到餐桌的全球食品供應鏈的機構之一是一些創新公司,其中包括Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF), 美國達爾令國際 (NASDAQ: CALM), 卡拉沃養殖 (NASDAQ: CVGW), Darling Ingredients Inc. (NYSE: DAR)和FMC Corporation (NYSE: FMC)。

One notable innovator that's developing potential game-changing solutions is Bee Vectoring Technologies International Inc. (BVT) (CSE: BEE) (OTCQB: BEVVF), which employs commercially-reared bees to deliver biological pesticide alternatives directly to crops. This innovative approach is making strides in the $250 billion crop protection and fertilizer industry.

一家值得注意的創新者是Bee Vectoring Technologies International Inc. (BVT) (CSE: BEE) (OTCQB: BEVVF),它利用商業養殖的蜜蜂直接向作物傳送生物農藥替代品。這種創新方法正在向價值2500億美元的作物保護和肥料行業邁進。

BVT is concentrating on the development of biological agricultural products ("biologicals") designed to replace traditional chemical pesticides and fertilizers. The biologicals sector is witnessing remarkable growth, with a projected compound annual growth rate (CAGR) of 13.3%. This market is expected to reach a valuation of US$45.3 billion by 2032, according to research from DataHorizzon.

BVT正在專注於開發旨在取代傳統化學農藥和肥料的生物農業產品(「生物製品」)。生物製品行業正在經歷着驚人的增長,預計複合年增長率將達到13.3%。據DataHorizzon的研究,這個市場預計將在2032年達到453億美元的估值。

Most recently, BVT received official approval in Mexico from the country's health authority responsible for registration of plant protection products, COFEPRIS. As per the announcement, BVT's proprietary Vectorite with Clonostachys Rosea CR-7 (CR-7) was approved for use as a fungicide on commercial crops.

最近,BVT在墨西哥獲得了該國負責植物保護產品註冊的衛生管理局COFEPRIS的官方批准。根據公告,BVT的Vectorite with Clonostachys Rosea CR-7 (CR-7) 獲得了在商業作物上用作殺真菌劑的批准。

"The success of BVT receiving regulatory approval for its product in Mexico is consistent with our strategy to focus on increasing the Company's addressable market through geographic market expansion," said Ashish Malik, CEO of BVT. "With US EPA approval in 2019, and now by adding Mexico COFEPRIS approval allowing BVT's CR-7 to be sold in Mexico for the first time, we have significantly increased the market opportunity for commercial sales of the Company's proprietary biological fungicide."

「BVT的產品在墨西哥獲得法規批准的成功符合了我們將重點放在通過地理市場擴張增加公司可尋址市場的策略,」 BVT首席執行官Ashish Malik說。 「在2019年獲得美國環保署的批准,現在再加上墨西哥COFEPRIS的批准允許BVT的CR-7首次在墨西哥銷售,這極大地增加了公司專有生物殺真菌劑的商業銷售市場機會。」

The approval covers delivery of CR-7 using both bumble bees and honeybees on various high value crops, including the berry group of crops and indoor vegetables. Mexico's agricultural sector presents a significant market opportunity for BVT's natural precision agriculture system.

該批准涵蓋了使用熊蜂和蜜蜂在各種高價值作物上傳送 CR-7,包括漿果作物和室內蔬菜。墨西哥的農業部門爲BVT的自然精準農業系統提供了巨大的市場機會。

In 2019, the country's production included 41,600 acres of strawberries, 12,100 acres of blueberries, and over 377,000 acres of tomatoes and peppers. That same year, the U.S. imported fresh and processed fruits and vegetables from Mexico valued at US$15.6 billion. While Mexico currently spends US$1.3 billion annually on pesticides, a growing number of growers are shifting toward biological alternatives that enhance quality, improve food safety, and reduce reliance on chemicals.

2019年,該國的產量包括41,600英畝草莓、12,100英畝藍莓、超過377,000英畝的番茄和辣椒。同年,美國從墨西哥進口了價值15.6億美元的新鮮和加工的水果和蔬菜。雖然墨西哥目前每年耗資13億美元用於殺蟲劑,但越來越多的種植者正在轉向增強質量、提高食品安全、減少對化學品的依賴的生物替代品。

"Having already completed demos with some berry growers in Mexico, and with the registration now in hand, BVT is in a great place to secure a commercial arrangement with a partner to bring our system to market in Mexico," added Malik. "Mexico is a strategic market for BVT – being an export-oriented country where the growers are keen to adopt low- or no-chemical solutions to fight diseases and increase crop yields, BVT's all-natural solution together with the classification of CR-7 being exempt from residue tolerance in the US, will provide them with a competitive advantage."

「在墨西哥已經與一些漿果種植者完成演示後,現在獲得註冊,BVT將是與合作伙伴達成商業協議,將我們的系統推向墨西哥市場的有利地位,」 Malik補充說。「墨西哥是BVT的戰略市場——它是一個以出口爲導向的國家,種植者渴望採用低或無化學品的解決方案來抵禦疾病並提高作物產量,BVT的全天然解決方案與CR-7在美國排除殘留寬容度的分類一起,將爲他們提供競爭優勢。」

In the past year, BVT has also reached important milestones, including starting trials in Spain with Agrobío, and partnering with MBFi in South Africa. Additionally, BVT achieved its first sale of CR-7 to BioSafe Systems. Motivated by the successful results from the Michigan State University trial, BVT plans to replicate these trials in the coming years to further confirm the effectiveness of CR-7.

在過去的一年中,BVT還實現了重要的里程碑,包括在西班牙與Agrobío開始試驗,並與南非的MBFi合作。此外,BVT實現了CR-7首次銷售給BioSafe Systems。受到密歇根州立大學試驗成功的結果的激勵,BVT計劃在未來幾年內複製這些試驗,以進一步確認CR-7的有效性。

Prior to releasing its Q4 2024 and FY 2024 financial results, Cal-Maine Foods, Inc. (NASDAQ: CALM) further strengthened its title of the largest producer and distributor of fresh shell eggs in the USA by acquiring the egg production assets of ISE America.

在發佈Q4 2024和2024財年財務業績之前,Cal-Maine Foods, Inc. (NASDAQ: CALM)通過收購ISE America的蛋製品資產進一步鞏固了在美國鮮貝蛋生產和分銷業的最大生產商和經銷商的頭銜。

The acquired ISE assets encompass commercial shell egg production and processing facilities with a current capacity of approximately 4.7 million laying hens, including 1.0 million cage-free hens and 1.2 million pullets. The acquisition also includes feed mills, around 4,000 acres of land, inventories, and an egg products breaking facility. Additionally, the assets feature an extensive customer distribution network across the Northeast and Mid-Atlantic states, with production operations located in Maryland, New Jersey, Delaware, and South Carolina.

收購的ISE資產包括商業鳥蛋生產和加工設施,目前容量約470萬隻產蛋雞,包括100萬隻無籠飼養的雞和120萬隻雛雞。收購還包括飼料廠、大約4000英畝的土地、庫存和一家蛋製品打破設施。此外,該資產擁有跨東北和中大西洋州的廣泛客戶分銷網絡,生產活動設在馬里蘭州、新澤西州、特拉華州和南卡羅來納州。

"We are excited about the opportunity to significantly enhance our market reach in the Northeast and Mid-Atlantic states with the acquisition of these assets from ISE," said Sherman Miller, President and CEO of Cal-Maine Foods. "The added production and distribution capabilities will allow us to serve new customers and expand capacity, particularly in the Northeast, which is largely a new territory for Cal-Maine Foods."

Cal-Maine Foods總裁兼首席執行官Sherman Miller表示:「收購ISE的資產使我們非常興奮,這將使我們在東北和中大西洋州顯著增強市場覆蓋。增加的產能和分銷能力將使我們能夠爲新客戶服務並擴大產能,特別是在Cal-Maine Foods基本上是未開發的東北地區。」

Coming off of the sale of its Fresh Cut business for $83 million, Calavo Growers, Inc. (NASDAQ: CVGW) is now even more focused on its flagship avocado operations, along with its other quality produce that includes tomatoes and papayas. Prior to the sale, Calavo reported its Q2 2024 financial results, which included a 16.5% increase in total net sales from the prior year quart to $184.4 million, and an 18.9% increase in its grown segment sales.

在將其新鮮切割業務出售8300萬美元后,Calavo Growers, Inc. (NASDAQ: CVGW)現在將更加專注於其旗艦鱷梨業務,以及其其他質量產品,包括番茄和木瓜。在出售之前,Calavo報告了2024財年第二季度的財務業績,總淨銷售額從去年同期的1.6億美元增長了16.5%,種植部門銷售額增長了18.9%。

"We are pleased to announce that the sale of our Fresh Cut business has been finalized, which will allow us to focus on our core avocado and guacamole businesses," said Lee Cole, President and CEO of Calavo Growers. "We would like to thank the team members of the Fresh Cut business for their hard work and years of service to Calavo."

Calavo Growers總裁兼首席執行官Lee Cole表示:「我們很高興地宣佈,我們的新鮮切割業務的銷售已經完成,這將使我們能夠專注於我們的核心鱷梨和鱷梨醬業務。我們要感謝Fresh Cut業務的團隊成員爲Calavo服務的多年辛勤工作。」

Darling Ingredients Inc. (NYSE: DAR) is an innovative company that takes material from the animal agriculture and food industries, and transforms them into valuable ingredients that nourish people, feed animals and crops, and fuel the world with renewable energy. Recently Darling announced a target to reduce Scope 1 and 2 emissions 42% by 2030, which aligns with its commitment to the Science Based Targets initiative (SBTi).

Darling Ingredients Inc. (NYSE: DAR)是一家創新公司,從動物農業和食品行業中提取材料,並將它們轉化爲有價值的成分,用於滋養人類、餵養動物和作物,並用可再生能源爲世界提供動力。最近,達能宣佈了一個目標,到2030年減少範圍1和2的排放量42%,這與其對科學基礎目標倡議(SBTi)的承諾相一致。

"Darling Ingredients plays an important role in circularity. We help entire industries be less wasteful and more sustainable by providing valuable ingredients that help lower our customers' carbon footprint," said Randall C. Stuewe, Chairman and CEO of Darling Ingredients. "2023 was a year of setting up for continued success, and I'm excited for the future as we look to further strengthen our business in a sustainable way."

Darling Ingredients董事長兼首席執行官Randall C. Stuewe表示:「Darling Ingredients在循環利用中發揮着重要的作用。我們通過提供有助於降低客戶碳足跡的有價值成分,幫助整個行業減少浪費和更可持續。2023年是一個爲持續發展奠定基礎的一年,我對未來感到興奮,我們正在努力在可持續的方式下進一步加強我們的業務。」

Back in April, Darling announced it had identified collagen peptide profiles for targeted health benefits. During scientific trials, these active collagen peptide profiles demonstrated that collagen can be beneficial for a variety of common health and wellness concerns, such as reducing post-meal blood sugar spike, in a natural way, in healthy individuals.

今年四月,Darling宣佈已確定了具有有針對性的健康效益的膠原蛋白肽組合。在科學試驗中,這些活性膠原蛋白肽組合表明,膠原蛋白能夠以一種自然的方式對多種常見的健康和健身問題有益,例如減少餐後血糖水平。

Leading global agricultural sciences company FMC Corporation (NYSE: FMC) recently released its Q2 2024 earnings report, which showcased the company at the higher end of its guidance range, and led to an update on its full-year outlook. Within the report, FMC reported revenue of $1.04 billion, up 2% from Q2 2023, and an adjusted EBITDA of $202 million, up 8% over the same period.

領先的全球農產品科學公司FMC(紐交所:FMC)最近發佈了其2024年第二季度業績報告,並展示了公司的業務範圍更上一層樓,這也爲其全年展望更新提供了基礎。在該報告中,FMC公司報告了10.4億美元的營業收入,較2023年第二季度增長2%,調整後的EBITDA爲2.02億美元,同比增長8%。

"Demand improved during the second quarter, resulting in a pronounced increase in our sales volumes, most notably within the United States and Brazil, despite customers continuing to actively manage inventory," said Pierre Brondeau, Chairman and CEO of FMC. "Higher sales, as well as cost benefits from our ongoing restructuring, led to adjusted EBITDA toward the high end of our guidance range."

「第二季度需求有所改善,儘管客戶繼續積極管理庫存,但我們的銷售量顯著提高,尤其是在美國和巴西市場。」 FMC董事長兼首席執行官Pierre Brondeau表示,「更高的銷售額以及我們不斷重組帶來的成本效益,導致我們的調整後EBITDA在我們的指導範圍的高端。」

Prior to the report, FMC signed a definitive agreement to sell its Global Specialty Solutions (GSS) business to Envu for $350 million. And prior to that, FMC obtained registration in Brazil for two herbicides powered by Isoflex active, the company's brand name for a novel herbicide used in cereals. The two new formulations will provide growers with new tools to effectively manage herbicide resistance across a wide range of agronomic practices.

在發佈這份報告之前,FMC與Envu簽署了一份明確的協議,以3.5億美元的價格將其全球特種解決方案(GSS)業務出售給了Envu。在此之前,FMC以其品牌Isoflex活性劑爲主推出兩種除草劑在巴西註冊。這兩種新配方將爲種植戶提供新的工具,以有效地管理在廣泛習慣中的除草劑抗性問題。

Article Source:

文章來源:

USA News Group
Editorial Staff

美國資訊集團
編輯部

CONTACT:

聯繫人:

USA NEWS GROUP
[email protected]
(604) 265-2873

(604) 265-2873
[email protected]
(604) 265-2873

DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. USA News Group is a wholly-owned subsidiary of Market IQ Media Group, Inc. ("MIQ"). MIQ has been paid a fee for Bee Vectoring Technologies International Inc. advertising and digital media from the company directly. There may be 3rd parties who may have shares of Bee Vectoring Technologies International Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ own shares of Bee Vectoring Technologies International Inc. which were purchased in the open market, and reserve the right to buy and sell, and will buy and sell shares Bee Vectoring Technologies International Inc. at any time without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material disseminated by MIQ has been approved by the above mentioned company; this is a paid advertisement, we currently own shares of Bee Vectoring Technologies International Inc. and will buy and sell shares of the company in the open market, or through private placements, and/or other investment vehicles.

免責聲明: 本刊物中的所有內容都不應視爲個性化的金融建議。我們沒有取得證券法的許可,以解決您特定的財務情況。我們的員工與您之間的任何溝通都不應視爲個性化的金融建議。在作出任何投資決策之前,請諮詢持牌的金融顧問。本文爲付費廣告,既不是買賣任何證券的要約也不構成對任何證券的推薦。我們不持有任何投資許可證,因此,我們不具備提供投資建議的資格。本報告或電子郵件中的內容沒有針對任何個體情況提供。USA News Group是Market IQ Media Group, Inc.(以下簡稱「MIQ」)的全資子公司。MIQ已獲得了Bee Vectoring Technologies International Inc.公司的廣告和數字媒體費用。可能有第三方持有Bee Vectoring Technologies International Inc.股票,並且可能清算其股票,這可能會對該股票的價格產生負面影響。這種補償構成了一種利益衝突,從而影響我們在通信時保持客觀性的能力。由於這種衝突,我們強烈建議個人不要以本出版物爲基礎做出任何投資決策。MIQ的所有者/運營商持有Bee Vectoring Technologies International Inc.的股票,這些股票是在公開市場上購買的,並保留權利隨時購買和出售股票,而不需要進一步通知。我們還希望作爲持續數字媒體努力的進一步補償,增加該公司的能見度,不會給出進一步通知,但是讓此免責聲明作爲通知,MIQ發佈的所有材料都已經得到上述公司的批准;這是一篇付費廣告,我們目前持有Bee Vectoring Technologies International Inc.的股票,並將在公開市場上或通過私人配售和/或其他投資車輛買入和賣出Bee Vectoring Technologies International Inc.的股票。

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

免責聲明:本出版物中的任何內容都不應被視爲個性化的財務顧問。我們未獲得證券法的許可以解決您的特定財務狀況。我們員工向您的任何溝通被視爲個性化的財務建議。在做任何投資決定之前,請諮詢持牌的金融顧問。這是一次付費廣告,既不是買入也不是賣出任何證券的建議。我們沒有投資許可證,因此沒有資格提供投資建議。報告或電子郵件中的內容並未針對任何個人情況提供。美國資訊集團是Market IQ Media Group,Inc.(「MIQ」)的全資子公司。MIQ已從公司直接獲得了Oncolytics Biotech Inc.廣告和數字媒體的費用。可能會有第三方擁有Oncolytics Biotech Inc.的股份,並出售他們的股份,這可能會對股票價格產生負面影響。這種補償構成了利益衝突,因此強烈建議個人不要以此出版物作爲任何投資決策的基礎。MIQ的所有者/運營商擁有Oncolytics Biotech Inc.的股份,這些股份是在公開市場上購買的,並保留在任何時候在不發出進一步通知的情況下開始和持續地買賣Oncolytics Biotech Inc.的股份的權利。我們還預期進一步的補償作爲增加該公司的數字媒體投入,將不再給出進一步的通知,但讓此免責聲明作爲說明,即所有由MIQ傳播的材料,包括本文,都已得到一致同意。Oncolytics Biotech Inc.;這是一次付費廣告,我們目前擁有Oncolytics Biotech Inc.的股份,並將在公開市場上或通過私募股份以及/或其他投資工具買賣該公司的股份。

SOURCE USA News Group

資源來自USA News Group

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論